# TriplePoint Venture Growth BDC Corp.: financial statements, quarterly

TPVG · NYSE · CIK 1580345 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tpvg.md) · [Financials](/companies/tpvg/financials.md) · [Filings](/companies/tpvg/filings.md) · [Insiders](/companies/tpvg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tpvg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [2.1](/filings/0001580345-24-000047.md) | [(28.8) d](/filings/0001580345-26-000008.md) | [8.0](/filings/0001580345-25-000018.md) | [8.6](/filings/0001580345-25-000025.md) | [22.6](/filings/0001580345-25-000032.md) | [(7.2) d](/filings/0001580345-26-000008.md) | [12.7](/filings/0001580345-26-000021.md) | [13.2](/filings/0001580345-26-000025.md) | [15.2](/filings/0001580345-25-000032.md) | [8.1 d](/filings/0001580345-26-000008.md) | [6.2](/filings/0001580345-26-000021.md) | [10.7](/filings/0001580345-26-000025.md) |
| Diluted EPS | $ per share | [0.54](/filings/0001580345-24-000047.md) | not reported | [0.41](/filings/0001580345-25-000018.md) | [0.33](/filings/0001580345-25-000025.md) | [0.35](/filings/0001580345-25-000032.md) | not reported | [0.27](/filings/0001580345-26-000021.md) | [0.28](/filings/0001580345-26-000025.md) | [0.26](/filings/0001580345-25-000032.md) | not reported | [0.23](/filings/0001580345-26-000021.md) | [0.21](/filings/0001580345-26-000025.md) |
| Basic EPS | $ per share | [0.54](/filings/0001580345-24-000047.md) | not reported | [0.41](/filings/0001580345-25-000018.md) | [0.33](/filings/0001580345-25-000025.md) | [0.35](/filings/0001580345-25-000032.md) | not reported | [0.27](/filings/0001580345-26-000021.md) | [0.28](/filings/0001580345-26-000025.md) | [0.26](/filings/0001580345-25-000032.md) | not reported | [0.23](/filings/0001580345-26-000021.md) | [0.21](/filings/0001580345-26-000025.md) |

- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [105](/filings/0001580345-24-000047.md) | [153](/filings/0001580345-26-000008.md) | [0.1](/filings/0001580345-25-000018.md) | [50.4](/filings/0001580345-25-000025.md) | [48.3](/filings/0001580345-25-000032.md) | [45.9](/filings/0001580345-26-000008.md) | [34.7](/filings/0001580345-26-000021.md) | [62.4](/filings/0001580345-26-000025.md) | [20.0](/filings/0001580345-25-000032.md) | [20.4](/filings/0001580345-26-000025.md) | [8.6](/filings/0001580345-26-000021.md) | [14.0](/filings/0001580345-26-000025.md) |
| Total assets | $m | [998](/filings/0001580345-23-000039.md) | [979](/filings/0001580345-25-000005.md) | [783](/filings/0001580345-24-000030.md) | [771](/filings/0001580345-24-000039.md) | [778](/filings/0001580345-24-000047.md) | [763](/filings/0001580345-26-000008.md) | [735](/filings/0001580345-25-000018.md) | [788](/filings/0001580345-25-000025.md) | [836](/filings/0001580345-25-000032.md) | [840](/filings/0001580345-26-000025.md) | [807](/filings/0001580345-26-000021.md) | [809](/filings/0001580345-26-000025.md) |
| Total liabilities | $m | [624](/filings/0001580345-23-000039.md) | [633](/filings/0001580345-25-000005.md) | [441](/filings/0001580345-24-000030.md) | [418](/filings/0001580345-24-000039.md) | [414](/filings/0001580345-24-000047.md) | [417](/filings/0001580345-26-000008.md) | [388](/filings/0001580345-25-000018.md) | [440](/filings/0001580345-25-000025.md) | [480](/filings/0001580345-25-000032.md) | [486](/filings/0001580345-26-000025.md) | [456](/filings/0001580345-26-000021.md) | [456](/filings/0001580345-26-000025.md) |
| Long-term debt | $m | [600](/filings/0001580345-23-000039.md) | [605](/filings/0001580345-25-000005.md) | [430](/filings/0001580345-24-000030.md) | [401](/filings/0001580345-24-000039.md) | [399](/filings/0001580345-24-000047.md) | [395](/filings/0001580345-26-000008.md) | [375](/filings/0001580345-25-000018.md) | [420](/filings/0001580345-25-000025.md) | [466](/filings/0001580345-25-000032.md) | [464](/filings/0001580345-26-000025.md) | [442](/filings/0001580345-26-000021.md) | [440](/filings/0001580345-26-000025.md) |
| Shareholders' equity | $m | [374](/filings/0001580345-24-000047.md) | [346](/filings/0001580345-26-000008.md) | [341](/filings/0001580345-25-000025.md) | [353](/filings/0001580345-25-000032.md) | [364](/filings/0001580345-25-000032.md) | [346](/filings/0001580345-26-000025.md) | [347](/filings/0001580345-26-000025.md) | [349](/filings/0001580345-26-000025.md) | [355](/filings/0001580345-25-000032.md) | [354](/filings/0001580345-26-000025.md) | [351](/filings/0001580345-26-000025.md) | [353](/filings/0001580345-26-000025.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [70.5 d](/filings/0001580345-24-000047.md) | [43.1 d](/filings/0001580345-26-000008.md) | [18.2](/filings/0001580345-25-000018.md) | [76.4 d](/filings/0001580345-25-000025.md) | [11.7 d](/filings/0001580345-25-000032.md) | [46.6 d](/filings/0001580345-26-000008.md) | [(4.9)](/filings/0001580345-26-000021.md) | [(12.7) d](/filings/0001580345-26-000025.md) | [(70.0) d](/filings/0001580345-25-000032.md) | [30.6 d](/filings/0001580345-26-000008.md) | [(6.4)](/filings/0001580345-26-000021.md) | [16.8 d](/filings/0001580345-26-000025.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.4](/filings/0001580345-23-000039.md) | [35.3](/filings/0001580345-24-000030.md) | [35.4](/filings/0001580345-24-000039.md) | [35.6](/filings/0001580345-24-000047.md) | [37.6](/filings/0001580345-25-000018.md) | [38.7](/filings/0001580345-25-000025.md) | [40.0](/filings/0001580345-25-000032.md) | [40.1](/filings/0001580345-26-000021.md) | [40.2](/filings/0001580345-26-000025.md) | [40.3](/filings/0001580345-25-000032.md) | [40.5](/filings/0001580345-26-000021.md) | [40.6](/filings/0001580345-26-000025.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,709,723 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001580345-26-000025.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.